Bourgeon Capital Management LLC Bristol Myers Squibb CO Transaction History

Bourgeon Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $3,668 - $4,297	-62 Closed	0 $0
Q2 2020 Jul 27, 2020	SELL	$54.82 - $64.09 $660,581 - $772,284	-12,050 Reduced 99.49%	62 $4,000
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $561,996 - $816,712	12,112 New	12,112 $675,000
Q4 2019 Feb 04, 2020	SELL	$49.21 - $64.19 $462,574 - $603,386	-9,400 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $183,483 - $217,545	-4,290 Reduced 31.34%	9,400 $477,000
Q1 2019 Apr 29, 2019	BUY	$45.12 - $53.8 $617,692 - $736,522	13,690 New	13,690 $653,000
Q4 2017 Feb 05, 2018	SELL	$59.94 - $65.35 $563,256 - $614,093	-9,397 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $518,996 - $598,964	9,397	9,397 $599,000

2,532

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bourgeon Capital Management LLC with notifications on news.